Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition

Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition

Background Immune checkpoint inhibitor (ICI) therapy improves the survival of patients with advanced bladder cancer (BLCA); however, its overall effectiveness is limited, and many patients still develop immunotherapy resistance. The leucine-rich repeat and fibronectin type-III domain-containing prot...

Full description

Bibliographic Details
Main Authors:	Xu Chen, Anze Yu, Jiao Hu, Liangmin Fu, Gaowei Huang, Dingshan Deng, Mingxiao Zhang, Yinghan Wang, Guannan Shu, Lanyu Jing, Huihuang Li, Taowei Yang, Jinhuan Wei, Zhenhua Chen, Xiongbing Zu, Junhang Luo
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-10-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/11/10/e007230.full

Similar Items

SALM/Lrfn Family Synaptic Adhesion Molecules
by: Eunkyung Lie, et al.
Published: (2018-04-01)

Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma
by: Nana Wang, et al.
Published: (2025-02-01)

An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer
by: Zicheng Xiao, et al.
Published: (2022-09-01)

BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity
by: Zhiyong Cai, et al.
Published: (2023-03-01)

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study
by: Ke Xu, et al.
Published: (2023-06-01)

A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study
by: Huihuang Li, et al.
Published: (2022-11-01)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
by: Huihuang Li, et al.
Published: (2022-09-01)

Dysregulation of erythropoiesis and altered erythroblastic NMDA receptor-mediated calcium influx in Lrfn2-deficient mice.
by: Ryuta Maekawa, et al.
Published: (2021-01-01)

Sorting nexin-27 regulates AMPA receptor trafficking through the synaptic adhesion protein LRFN2
by: Kirsty J McMillan, et al.
Published: (2021-07-01)

CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis
by: Yang Jiang, et al.
Published: (2022-10-01)

Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer
by: Dingshan Deng, et al.
Published: (2024-11-01)

Correction: CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis
by: Yang Jiang, et al.
Published: (2022-11-01)

Oncogenic ACSM6 impairs CD8+ T cell-based immune response in bladder cancer
by: Zhenyu Nie, et al.
Published: (2024-09-01)

Expression of Concern: Dysregulation of erythropoiesis and altered erythroblastic NMDA receptor-mediated calcium influx in Lrfn2-deficient mice.
by: PLOS ONE Editors
Published: (2023-01-01)

Expression of Concern: Dysregulation of erythropoiesis and altered erythroblastic NMDA receptor-mediated calcium influx in Lrfn2-deficient mice
Published: (2023-01-01)

A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts
by: Dingshan Deng, et al.
Published: (2023-05-01)

Crosstalk between autophagy and immune cell infiltration in the tumor microenvironment
by: Tiantian Yang, et al.
Published: (2023-02-01)

S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8+ T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma
by: Huihuang Li, et al.
Published: (2023-09-01)

Deciphering the role of miR-187-3p/LRFN1 axis in modulating progression, aerobic glycolysis and immune microenvironment of clear cell renal cell carcinoma
by: Wenhao Xu, et al.
Published: (2022-07-01)

Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
by: Belaydi Othmane, et al.
Published: (2022-11-01)

EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1
by: Yihui Pan, et al.
Published: (2023-04-01)

Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
by: Luzhe Yan, et al.
Published: (2025-02-01)

Mapping the intrinsic potential of water infiltration in urban subsurface: feedback from France
by: Flora Lucassou, et al.
Published: (2024-09-01)

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts
by: Chunyu Zhang, et al.
Published: (2023-04-01)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
by: Zhiyong Cai, et al.
Published: (2022-09-01)

Influence mechanism of vegetation infiltration effect on shallow landslides of granite residual soil
by: Jingye CHEN, et al.
Published: (2023-05-01)

KM04416 suppressed lung adenocarcinoma progression by promoting immune infiltration
by: Yalan Lin, et al.
Published: (2024-07-01)

Potent-by-design : amino acids mimicking porous nanotherapeutics with intrinsic anticancer targeting properties
by: Wu, Zhuoran, et al.
Published: (2022)

Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma
by: Hansen Lin, et al.
Published: (2023-05-01)

Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8+ T Cell Immunity against Tumor
by: Anze Yu, et al.
Published: (2023-01-01)

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer
by: Zhi Liu, et al.
Published: (2021-12-01)

TGFβ-Associated Signature Predicts Prognosis and Tumor Microenvironment Infiltration Characterization in Gastric Carcinoma
by: Siyuan Liu, et al.
Published: (2022-05-01)

Nanoporous Zeolite Thin Film-Based Fiber Intrinsic Fabry-Perot Interferometric Sensor for Detection of Dissolved Organics in Water
by: Hai Xiao, et al.
Published: (2006-08-01)

Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework
by: Songyun Zhao, et al.
Published: (2023-04-01)

VNN1 as a potential biomarker for sepsis diagnosis and its implications in immune infiltration and tumor prognosis
by: Wei Guan, et al.
Published: (2023-08-01)

Pan-Cancer Analysis Reveals Disulfidoptosis-Associated Genes as Promising Immunotherapeutic Targets: Insights Gained from Bulk Omics and Single-Cell Sequencing Validation
by: Borui Xu, et al.
Published: (2024-01-01)

Prognostic value and immune-infiltration pattern of FOXD3-AS1 in patients with glioma
by: Zhenhua Chen, et al.
Published: (2023-04-01)

Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms
by: Pradeep K. Singh, et al.
Published: (2022-10-01)

Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma
by: Dingshan Deng, et al.
Published: (2022-08-01)

Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
by: Li Jiang, et al.
Published: (2018-12-01)